Expression of osteopontin, an inhibitor of skeletal mineralization, did not differ between patients with non-transplant CKD, those status-post kidney transplantation, and those with heart or liver allografts, suggesting that expression of this specific protein may not be altered by CKD or by the presence of immune-suppression. Here, SPP1 is linked to chronic kidney disease.